Invectys
View On Demand

Treating Cancer With A Single Injection

About the Event


Imagine treating cancer tumors with a single injection without affecting other organs in the body!

Invectys is a clinical stage cancer immunotherapy company developing breakthrough treatments based on a novel precision target, the Human Leukocyte Antigen-G (HLA-G). More than 70 percent of human cancers express HLA-G thus by targeting the those expressors, therapies go directly to the tumor minimizing damage to other organs. In animal models, T-Cell therapy targeting HLA-G cleared the lung of cancer metastases just 20 days after treatment.

Invectys will be moving into Phase 1 Clinical Trials this year, with the goal of completing Phase 2a on their first platform in 2024.

Join our webinar with Invectys President and CEO, Praveen Tyle, to learn more about the company’s three platforms and the technology that has the potential to cure metastatic cancers.

View On-Demand


SHARE THIS EVENT
Share on facebook
Share on twitter
Share on linkedin

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.